QSS
TCRT icon

Quantitative Systematic Strategies’s Alaunos Therapeutics TCRT Stock Holding History

Quantitative Systematic Strategies’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-106
Closed -$40K – 742
2020
Q3 		$40K Buy
+106
New +$46.8K 0.01% 575
2019
Q1 		– Sell
-130
Closed -$36K – 628
2018
Q4 		$36K Sell
130
-139
-52% -$55K 0.01% 666
2018
Q3 		$129K Buy
+269
New +$115K 0.02% 559

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Quantitative Systematic Strategies's TCRT Position: Q4 2020 in Review

Quantitative Systematic Strategies sold out of Alaunos Therapeutics (TCRT) in Q4 2020, closing a stake of 106 shares — an estimated $40K sold.

Quantitative Systematic Strategies first reported a position in TCRT in Q3 2018 and held it in 3 quarters. The position peaked at $129K in Q3 2018. 156 funds tracked by Wall St. Rank hold TCRT as of Q4 2020.

  • Quantitative Systematic Strategies reported no remaining Alaunos Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 106 Alaunos Therapeutics shares in Q4 2020, an estimated $40K.
  • Quantitative Systematic Strategies first reported a position in Alaunos Therapeutics in Q3 2018 and held it in 3 quarters.
  • Quantitative Systematic Strategies's Alaunos Therapeutics position peaked at $129K in Q3 2018.
  • 156 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2020, filed 9 Feb 2021.